VINCERX PHARMA INC (VINC) Stock Balance Sheet
NASDAQ:VINC - Nasdaq - US92731L3042 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 685.00K | |||
| Cash Equivalents | 4.99M | 12.78M | 11.66M | 111.46M | 61.79M | |||
| Marketable Securities | N/A | 0.00 | 40.80M | N/A | N/A | |||
| Receivables | 1.04M | 1.29M | 1.37M | N/A | N/A | |||
| Other Current Assets | 382.00K | 657.00K | 2.13M | 382.00K | 106.00K | |||
| Total Current Assets | 6.41M | 14.73M | 55.96M | 111.84M | 791.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 2.33M | 3.24M | 4.18M | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 65.69M | |||
| Other Non-Current Assets | 1.59M | 1.16M | 81.00K | 1.65M | 82.00K | |||
| Total Non-Current Assets | 1.60M | 3.48M | 3.32M | 5.83M | 65.69M | |||
| TOTAL ASSETS | 8.01M | 18.22M | 59.29M | 117.68M | 66.48M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.24M | 2.92M | 5.95M | 738.00K | N/A | |||
| Accounts Payable | 2.03M | 2.50M | 3.06M | 6.73M | 115.00K | |||
| Other Current Liabilities | 8.00K | 191.00K | 144.00K | 6.45M | 1.00K | |||
| Total Current Liabilities | 5.28M | 5.61M | 9.16M | 13.92M | 116.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | |||
| Other Non-Current Liabilities | 0.00 | 1.39M | 2.46M | 3.44M | 2.30M | |||
| Total Non-Current Liabilities | 0.00 | 1.39M | 2.46M | 3.44M | 3.30M | |||
| TOTAL LIABILITIES | 5.28M | 7.00M | 11.62M | 17.36M | 3.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -189.19M | -159.11M | -121.34M | -55.97M | -121.00K | |||
| Additional Paid In Capital | 191.79M | 170.32M | 169.03M | 156.31M | 5.12M | |||
| Common Shares | 0.00 | 2.00K | 2.00K | 2.00K | 58.07M | |||
| Other Shareholders' Equity | 119.00K | 8.00K | -26.00K | -21.00K | 0.00 | |||
| Shares Outstanding | 2.24M | 1.07M | 1.06M | 1.05M | 410.00K | |||
| Tangible Book Value per Share | 1.22 | 10.49 | 44.89 | 95.27 | 153.83 | |||
| Total Shareholders' Equity | 2.72M | 11.22M | 47.67M | 100.32M | 63.07M | |||
| TOTAL LIABILITIES AND EQUITY | 8.01M | 18.22M | 59.29M | 117.68M | 66.48M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.02 | |||
| Current Ratio | 1.21 | 2.63 | 6.11 | 8.04 | 6.82 | |||
| Return On Assets (ROA) | -375.69% | -220.44% | -106.24% | -33.40% | -0.18% | |||
| Return On Equity (ROE) | -1104.04% | -357.84% | -132.13% | -39.18% | -0.19% | |||
All data in USD , ROIC based on taxRate of 0.21